Moderna's COVID-19 vaccine (SPIKEVAX) provisionally approved for use in individuals 6 years and older
The TGA has provisionally approved the Moderna COVID-19 vaccine, SPIKEVAX, for use in individuals aged 6 years and older.
Published
Related content
- Pfizer's COVID-19 vaccine (COMIRNATY) provisionally approved for use in individuals 5 years and overThe TGA has provisionally approved the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for use in individuals 5 years and older.
- TGA provisionally approves Moderna COVID-19 vaccine (SPIKEVAX) for use in children from 6 monthsThe TGA has provisionally approved a paediatric dose of the Moderna COVID-19 vaccine, SPIKEVAX, for use in individuals aged 6 months to less than 6 years (6 months to 5 years).
- TGA provisionally approves Moderna’s COVID-19 vaccine for use as a booster dose in individuals 12 years and olderOn 19 October 2022, the TGA provisionally approved Moderna's COVID-19 vaccine, SPIKEVAX (elasomeran), for use as a booster dose in individuals aged 12 years and older.